Tibet Huaxi Pharmaceutical Group

Tibet Huaxi Pharmaceutical Group is a prominent pharmaceutical enterprise based in Lhasa, Tibet, specializing in the modernization and industrialization of traditional Tibetan medicine. Founded in 1994, the company leverages the unique biological resources of the Qinghai-Tibet Plateau to develop ethnic medicines and modern pharmaceuticals. Its flagship product line, the Nuodikang series, utilizes Rhodiola extracts for the treatment of cardiovascular and cerebrovascular conditions. The group operates multiple GMP-certified production lines and maintains a significant market presence as the controlling shareholder of the publicly listed Tibet Rhodiola Pharmaceutical Holding. By integrating ancient medical wisdom with modern biotechnology, Tibet Huaxi provides therapeutic solutions for a wide range of chronic and complex diseases.